EAM
LTRN icon

Empery Asset Management’s Lantern Pharma LTRN Stock Holding History

Empery Asset Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51M Buy
+842,669
New +$2.47M 4.06% 7

Other funds holding LTRN

WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Empery Asset Management's LTRN Position: Q2 2026 in Review

Empery Asset Management opened a new position in Lantern Pharma (LTRN) in Q2 2026: 842,669 shares worth $3.51M. The stake represents 4.06% of the portfolio and ranks #7 among its holdings.

17 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Empery Asset Management held 842,669 shares of Lantern Pharma worth $3.51M as of Q2 2026.
  • Lantern Pharma was a new Empery Asset Management position in Q2 2026.
  • Lantern Pharma made up 4.06% of Empery Asset Management's portfolio in Q2 2026, its #7 holding.
  • 17 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Empery Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.